CURE Fail-to-Deliver

Direxion Daily Healthcare Bull 3X ETF (CURE) operates in the Financial Services sector, specifically the Asset Management - Leveraged industry, with a market capitalization near $155.6M, listed on AMEX, carrying a beta of 1.42 to the broader market. The Direxion Daily Healthcare Bull 3X Shares aims to achieve daily financial outcomes that are three times the performance of the Health Care Select Sector Index, prior to accounting for its fees and operational costs. public since 2011-06-15.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date
2026-05-27
Latest FTD Quantity
584
Latest Price
$93.34
30-Day Avg FTD
768
30-Day Total FTD
23.0K

Showing 30 days of SEC fail-to-deliver data for Direxion Daily Healthcare Bull 3X ETF.

Learn how fails-to-deliver is reported and how to read the data →

Frequently asked CURE fail to deliver questions

What is the latest CURE fail-to-deliver count?
As of May 27, 2026, Direxion Daily Healthcare Bull 3X ETF (CURE) fail-to-deliver quantity is 584 shares, with a 30-day average of 768 shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
What is the FTD aggregate net balance?
FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
How do CURE FTDs affect options pricing?
Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.